Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Outcomes after allo-HSCT for Diamond-Blackfan anemia

Carlo Dufour • 26 Aug 2020
EBMT 2020
Anemias

Carlo Dufour, MD, IRCCS Giannina Gaslini, Genoa, Italy, discusses the long-term outcomes after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for Diamond-Blackfan anemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Carlo Dufour

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
4:55
New guidelines for the management of neutropenia & challenges in this space
Carlo Dufour • 23 Apr 2023
2:17
BMF diagnosis with NGS and gene panels
Carlo Dufour • 1 Sep 2020
1:31
Autoimmune cytopenias following allo-HSCT
Carlo Dufour • 25 Aug 2020

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A 2-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
1:31
Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency
Hanny Al-Samkari • 9 Dec 2023
2:13
SATISFY: mitapivat in patients with erythrocyte membranopathies
Kevin Kuo • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals